FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

4148111000001107: Lanreotide 30mg powder and solvent for suspension for injection vials 1 vial (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21859501000001113 Lanreotide 30mg powder and solvent for suspension for injection vials 1 vial (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
21859601000001112 Lanreotide 30mg powder and solvent for suspension for injection vials 1 vial en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lanreotide 30mg powder and solvent for suspension for injection vials 1 vial VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Lanreotide 30mg powder and solvent for suspension for injection vials 1 vial Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lanreotide 30mg powder and solvent for suspension for injection vials 1 vial Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Lanreotide 30mg powder and solvent for suspension for injection vials 1 vial Is pack of Lanreotide 30mg powder and solvent for suspension for injection vials false Inferred relationship Existential restriction modifier
Lanreotide 30mg powder and solvent for suspension for injection vials 1 vial Has active ingredient Lanreotide acetate false Inferred relationship Existential restriction modifier
Lanreotide 30mg powder and solvent for suspension for injection vials 1 vial VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lanreotide 30mg powder and solvent for suspension for injection vials 1 vial VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Lanreotide 30mg powder and solvent for suspension for injection vials 1 vial Has active ingredient Lanreotide acetate false Inferred relationship Existential restriction modifier
Lanreotide 30mg powder and solvent for suspension for injection vials 1 vial Has manufactured dose form Powder for conventional release suspension for injection false Inferred relationship Existential restriction modifier
Lanreotide 30mg powder and solvent for suspension for injection vials 1 vial Is pack of Lanreotide 30mg powder and solvent for injection suspension vial false Inferred relationship Existential restriction modifier
Lanreotide 30mg powder and solvent for suspension for injection vials 1 vial Has VMP Lanreotide 30mg powder and solvent for injection suspension vial false Inferred relationship Existential restriction modifier
Lanreotide 30mg powder and solvent for suspension for injection vials 1 vial Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Lanreotide true Inferred relationship Existential restriction modifier
Lanreotide 30mg powder and solvent for suspension for injection vials 1 vial Has specific active ingredient Lanreotide acetate true Inferred relationship Existential restriction modifier
Lanreotide 30mg powder and solvent for suspension for injection vials 1 vial Has dispensed dose form Powder and solvent for suspension for injection true Inferred relationship Existential restriction modifier
Lanreotide 30mg powder and solvent for suspension for injection vials 1 vial Has basis of strength substance Lanreotide true Inferred relationship Existential restriction modifier
Lanreotide 30mg powder and solvent for suspension for injection vials 1 vial Has VMP Lanreotide 30mg powder and solvent for suspension for injection vials false Inferred relationship Existential restriction modifier
Lanreotide 30mg powder and solvent for suspension for injection vials 1 vial Has VMP Lanreotide 30mg powder and solvent for suspension for injection vials true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) 1 vial Is a True Lanreotide 30mg powder and solvent for suspension for injection vials 1 vial Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start